Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.92
- Piotroski Score 5.00
- Grade Market Perform
- Symbol (TMO)
- Company Thermo Fisher Scientific Inc.
- Price $555.97
- Changes Percentage (-0.66%)
- Change -$3.71
- Day Low $554.20
- Day High $565.88
- Year High $627.88
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
- Last Earnings 07/11/2024
- Ex-Dividend for 5/16 Dividend 09/13/2024
- Dividend Payable 10/15/2024
- Today N/A
- Next Earnings (Estimated) 01/29/2025
- Fiscal Year End N/A
- Average Stock Price Target $650.00
- High Stock Price Target $711.00
- Low Stock Price Target $505.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $15.60
- Trailing P/E Ratio 37.25
- Forward P/E Ratio 37.25
- P/E Growth 37.25
- Net Income $6.00 B
Income Statement
Quarterly
Annual
Latest News of TMO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Charles Deprima rushes for 2 fourth-quarter TDs and Harvard beats Dartmouth 31-27
Harvard football defeats Dartmouth 31-27 with Jaden Craig's 311 passing yards and Charles Deprima's two rushing touchdowns. This win marks Harvard's fifth consecutive victory and 14th win against Dart...
By AP NEWS | 5 days ago -
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight
Thermo Fisher Scientific Inc. demonstrates financial resilience in a challenging economic environment. With a diverse product portfolio and strategic acquisitions, TMO maintains steady revenue growth ...
By Yahoo! Finance | 6 days ago -
Coral Gables officials tour Biltmore hotel after claims hotel beached lease
Coral Gables officials found unauthorized upgrades at Biltmore Hotel. The city-owned building faces scrutiny for renovations done without permits. Mayor Lago is investigating the situation and emphasi...
By CBS News | 6 days ago
